Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia

2019189 citationsJournal Articlebronze Open Access

Authors

Bruce Spinowitz · New York Hospital Queens

Steven Fishbane · Hofstra University

Pablo E. Pérgola · Renal Associates P. A.

Simon D. Roger · Gosford Hospital

Edgar V. Lerma · University of Illinois Chicago

Javed Butler · University of Mississippi

Stephan von Haehling ·

Abstract

After achieving normokalemia, individualized once daily sodium zirconium cyclosilicate was associated with maintenance of normokalemia without substantial renin-angiotensin-aldosterone system inhibitor changes for ≤12 months.

Topics & Keywords

Potassium and Related Disorders Membrane-based Ion Separation Techniques Extraction and Separation Processes

UN Sustainable Development Goals

Life in Land

Publication Details

Published in: Clinical Journal of the American Society of Nephrology

Volume 14, Issue 6, pp. 798-809

DOI: 10.2215/cjn.12651018

Field-Weighted Citation Impact: 15.17